Press Release: Arisaph Pharmaceuticals : New Report Available: Arisaph Pharmaceuticals, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

(PR-inside.com) Arisaph Pharmaceuticals, Inc. (Arisaph) is a biopharmaceutical company that research, develops and markets new therapies for treatment of various diseases. The company offers its new therapies for the treatment of cardiometabolic diseases, cholesterol, diabetes and cancer. It uses its proprietary drug discovery platforms to develop differentiated medicines. Arisaph's proprietary specificity profiling and retro-inverso chiral chemistry technology platform is used to synthesize several lead drug candidates. The company is in the process of developing tumor activated pro-soft drugs for cancer. It partners with Fox Chase Cancer Center to screen novel and innovative cancer treatment compounds. Arisaph is headquartered in Boston, Massachusetts, ..